John J. Fiore

1.2k total citations
20 papers, 752 citations indexed

About

John J. Fiore is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, John J. Fiore has authored 20 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in John J. Fiore's work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer therapeutics and mechanisms (5 papers). John J. Fiore is often cited by papers focused on Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer therapeutics and mechanisms (5 papers). John J. Fiore collaborates with scholars based in United States. John J. Fiore's co-authors include Mark G. Kris, David P. Kelsen, Richard J. Gralla, Joseph O’Connell, R T Heelan, Gregory J. Riely, Robert B. Golbey, Susan Groshen, Naiyer A. Rizvi and Christopher G. Azzoli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

John J. Fiore

19 papers receiving 711 citations

Peers

John J. Fiore

ONCOL

PRM

EPIDE

SURGE

Kyoichi Okishio Japan

Yukiko Haga Japan

Jean‐Marc Tourani France

Joseph M. Quagliana United States

R. Stout United Kingdom

RB Davis United States

Marjan Rouzbahman Canada

Joseph A. Libnoch United States

George Lewandowski United States

A Topham United States

Kyoichi Okishio Japan

John J. Fiore

713 ×1.3

ONCOL

698 ×1.8

PRM

151 ×0.8

EPIDE

210 ×1.3

85 ×1.4

SURGE

Citations per year, relative to John J. Fiore John J. Fiore (= 1×) peers Kyoichi Okishio

Countries citing papers authored by John J. Fiore

Since Specialization

Citations

This map shows the geographic impact of John J. Fiore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Fiore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Fiore more than expected).

Fields of papers citing papers by John J. Fiore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Fiore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Fiore. The network helps show where John J. Fiore may publish in the future.

Co-authorship network of co-authors of John J. Fiore

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Fiore. A scholar is included among the top collaborators of John J. Fiore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Fiore. John J. Fiore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paik, Paul K., Rachel K. Kim, Linda S. Ahn, et al.. (2020). A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers. Clinical Cancer Research. 26(8). 1796–1802. 10 indexed citations

Paik, Paul K., Linda S. Ahn, Andrew J. Plodkowski, et al.. (2018). A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers.. Journal of Clinical Oncology. 36(15_suppl). e21035–e21035. 1 indexed citations

Pietanza, M. Catherine, Matthew D. Hellmann, John J. Fiore, et al.. (2016). Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. Journal of Thoracic Oncology. 11(6). 890–899. 2 indexed citations

Naidoo, Jarushka, Tunç Iyriboz, Kaitlin M. Woo, et al.. (2016). Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes. Clinical Lung Cancer. 17(5). e121–e129. 105 indexed citations

Riely, Gregory J., Helena A. Yu, Dennis Stephens, et al.. (2015). A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers.. Journal of Clinical Oncology. 33(15_suppl). 8064–8064. 10 indexed citations

Pietanza, M. Catherine, Kyuichi Kadota, Kety Huberman, et al.. (2012). Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker. Clinical Cancer Research. 18(4). 1138–1145. 122 indexed citations

Drilon, Alexander, Kety Huberman, Camelia S. Sima, et al.. (2012). 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial.. Journal of Clinical Oncology. 30(15_suppl). 7052–7052.

Rizvi, Naiyer A., Gregory J. Riely, Christopher G. Azzoli, et al.. (2008). Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(4). 639–643. 101 indexed citations

Madajewicz, Stefan, Daniela Matei, Andrzej P. Kudelka, et al.. (1999). Actual 5-Year Survival of Patients with Stage IIIB Breast Carcinoma: Phase II Trial of Methotrexate, Vinblastine, Adriamycin, Cisplatin, and Folinic Acid. Cancer Investigation. 17(7). 463–467. 4 indexed citations

10.

Matei, Daniela, Nabil Hagag, Stefan Madajewicz, et al.. (1995). Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma. Cancer. 76(8). 1330–1335. 8 indexed citations

11.

Zucker, Stanley, et al.. (1991). Proteinase‐alpha₂ macroglobulin complexes are not increased in plasma of patients with cancer. International Journal of Cancer. 48(3). 399–403. 7 indexed citations

12.

Snyder, Harry W., David H. Henry, Gerald L. Messerschmidt, et al.. (1991). Minimal toxicity during protein a immunoadsorption treatment of malignant disease: An outpatient therapy. Journal of Clinical Apheresis. 6(1). 1–10. 20 indexed citations

13.

Kelsen, David P., John J. Fiore, Donna Niedzwiecki, et al.. (1990). Metastatic Adenocarcinomas of Unknown Primary Site. American Journal of Clinical Oncology. 13(1). 55–60. 36 indexed citations

14.

Madajewicz, Stefan, John J. Fiore, & Mohammad H. Zarrabi. (1988). Clinical Experience with 5-FU/DDP ± OHDW Combination Chemotherapy in Patients with Advanced Colorectal Carcinoma. Advances in experimental medicine and biology. 244. 295–302. 2 indexed citations

15.

Kris, Mark G., R. Gralla, M. S. Wertheim, et al.. (1987). Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Lung Cancer. 3(2). 98–99. 61 indexed citations

16.

Fiore, John J., et al.. (1987). Systemic Absorption of a Leucovorin Mouth Wash: A Pharmacologic Study. Cancer Investigation. 5(2). 109–111. 5 indexed citations

17.

O’Connell, Joseph, Mark G. Kris, Richard J. Gralla, et al.. (1986). Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.. Journal of Clinical Oncology. 4(11). 1604–1614. 202 indexed citations

18.

Kris, Mark G., Richard J. Gralla, David P. Kelsen, et al.. (1985). Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer. American Journal of Clinical Oncology. 8(5). 377–379. 11 indexed citations

19.

Kris, Mark G., Richard J. Gralla, David P. Kelsen, et al.. (1985). Trial of Vindesine plus Mitomycin in Stage-3 Non-small Cell Lung Cancer. CHEST Journal. 87(3). 368–372. 25 indexed citations

20.

Fiore, John J. & Richard J. Gralla. (1984). Pharmacologic Treatment of Chemotherapy-Induced Nausea and Vomiting. Cancer Investigation. 2(5). 351–361. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact